Brought to you by:
System outage alert: Cyberattack sends medicine back to paper age
On Oct. 28, 2020, the University of Vermont Health Network—consisting of six hospitals in Vermont and upstate New York, was hit by a cyberattack.1 Leading up to the attack—the U.S. Cybersecurity and Infrastructure Security Agency (CISA) released a warning regarding ransomware…
FDA representatives respond to SWEDEPAD interim analysis, highlight need for continued study
Representatives from the Food and Drug Administration (FDA) referenced “important and reassuring” results from the recent interim analysis of the SWEDEPAD clinical trial in which patients with peripheral arterial disease (PAD) received treatment with paclitaxel-coated or uncoated endovascular devices. However, writing in…
Target 2021: SVS councils and committees drill down on key goals for year ahead (Part 5)
While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and dedication of SVS committee, council and task force members to deliver on the mission has remained…
Target 2021: SVS councils and committees drill down on key goals for year ahead (Part 4)
While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and dedication of SVS committee, council and task force members to deliver on the mission has remained…
Upcoming symposium for fellows: ‘Building a successful vascular practice’
A symposium designed to educate graduating vascular fellows on succeeding in a community or private practice as well as an academic setting is set to take place at the end of February. The 2021 Mote Symposium, hosted by the Mote…
Walking can relieve leg pain in people with PAD
Exercise can play an important role in treating peripheral arterial disease (PAD), a recent review by Amy Harwood, PhD, from the Centre for Sport and Exercise Life Sciences at Coventry University and the faculty of health sciences at the University of…
Resident Research Award deadline moved to Feb. 17
The deadline for the Society for Vascular Surgery (SVS) Resident Research Award has been extended to Feb. 17—a knock-on effect of the date shift for the Vascular Annual Meeting (VAM). The SVS Basic and Translational Research Committee selects one recipient…
Target 2021: SVS councils and committees drill down on key goals for year ahead (Part 3)
While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and dedication of SVS committee, council and task force members to deliver on the mission has remained…
Medicare cuts: Avoiding the ‘tragedy of the unprepared’
*The January 2021 issue of Vascular Specialist, which contained this story, went to press prior to the news that Congress had moved to halt cuts to Medicare. At the conclusion of a challenging 2020, we at the Society for Vascular Surgery (SVS)…
Target 2021: SVS councils and committees drill down on key goals for year ahead (Part 2)
While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and dedication of SVS committee, council and task force members to deliver on the mission has remained…